• user warning: Got error 28 from storage engine query: SELECT t.tid, t.* FROM term_data t INNER JOIN term_hierarchy h ON h.parent = t.tid WHERE h.tid = 12758 ORDER BY weight, name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 755.
  • user warning: Got error 28 from storage engine query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 49854 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Got error 28 from storage engine query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 13947 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Got error 28 from storage engine query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 11336 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.

sgen

Seattle Genetics Announced It Will Recieve A $5M Milestone P

Published on Mon, 06/27/2011 - 14:34
By FNNO Staff
seattle genetics, sgen, takeda, business, finance, stock, investing, trading

By FNNO Staff
fnnonline@gmail.com

Seattle Genetics Reported Mixed Q4 Results, Top Line Down 63% (SGEN)

Published on Tue, 02/08/2011 - 17:58
By Stephanie Shyu

President and Chief Executive Officer of Seattle Genetics, commented: "The strong brentuximab vedotin data we reported during the fourth quarter of 2010 highlighted an important year for Seattle Genetics, and position the company

seattle, genetics, nasdaq, sgen, earnings, quarter, shares, loss, financial, wall street, consensus, analysts, revenue, drug, health, medical, disease, patients, lymphoma, hodgkins, cancer, treatment, investment, clinical, trial, studies

Seattle Genetics (NASDAQ:SGEN) reported a Q4 loss of $0.34 per share, narrower than consensus estimates for a loss of $0.38 per share. Revenues for the quarter fell 63% year-over-year to $8.1 million, missing consensus estimates o

By Stephanie Shyu
sshyu@fnno.com

Seattle Genetics Prices 10 Mln Shares at $15.50 Each, Shares Off 2.5%

Published on Wed, 02/02/2011 - 10:33
By FNNO Staff
business, market, news, priced, seattle genetics, sgen, shares, stock, trade, update, value

Seattle Genetics (SGEN) says it priced 10 million shares at $15.50 each in a public offering. It has granted the underwriters a 30-day option to purchase up to an aggregate of 1.5 million additional shares of common stock to cover

By FNNO Staff
fnnonline@gmail.com

Most Popular Video News